Effect of hydroxyethyl starch infusion on colloid oncotic pressure in hypoproteinemic horses

Journal of the American Veterinary Medical Association

Volumn 218, Issue 7, 2001, Pages 1130-1135

  Jones, Peyton A ^a,c   Bain, Fairfield T ^b   Byars, T Douglas ^b   David, J Barry ^b,d   Boston, Raymond C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HAGYARD EQUINE MEDICAL INSTITUTE   (United States)

^c Benchmark Veterinary Services   (United States)

^d Blue Ridge Equine Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; EQUIDAE;

HETASTARCH; PLASMA PROTEIN; PLASMA SUBSTITUTE; SERUM ALBUMIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; COLLOID; FLUID THERAPY; HORSE; HORSE DISEASE; HYPOPROTEINEMIA; INTRAVENOUS DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PRESSURE; PROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

ANIMALS; BLOOD PROTEINS; COLLOIDS; FLUID THERAPY; HETASTARCH; HORSE DISEASES; HORSES; HYPOPROTEINEMIA; INFUSIONS, INTRAVENOUS; PLASMA SUBSTITUTES; PRESSURE; PROSPECTIVE STUDIES; SERUM ALBUMIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 0035319761     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2001.218.1130     Document Type: Article

References (49)

1. Starling EH. On the absorption of fluids from the connective tissue spaces. J Physiol (London) 1896;19:312-326.
2. Landis EM, Pappenheimer JR. Exchange of substances through the capillary walls. In: Hamilton WF, Dow P, eds. Handbook of physiology. Washington, DC: American Physiological Society, 1963;961-1034.
3. Roberts JS, Bratton SL. Colloid volume expanders: problems, pitfalls and possibilities. Drugs 1998;55:621-630.
4. Salmon JB, Mythen MG. Pharmacology and physiology of colloids. Blood Rev 1993;7:114-120.
5. Kaminski MV, Haase TJ. Albumin and colloid osmotic pressure implications for fluid resuscitation. Crit Care Clin 1992;8:311-321.
6. Astiz ME, Galera-Santiago A, Rackow EC. Intravascular volume and fluid therapy for severe sepsis. New Horiz 1993;1:127-136.
7. Haynes GR, Conroy JM, Baker JD, et al. Colloid oncotic pressure as a guide for the anesthesiologist in directing fluid therapy. South Med J 1989;82:618-623.
8. Weinstein PD, Doerfler ME. Systemic complications of fluid resuscitation. Crit Care Clin 1992;8:439-448.
9. Rady M. An argument for colloid resuscitation for shock. Acad Emerg Med 1994;1:572-579.
10. Harms BA, Kramer GC, Bodai BI, et al. Effect of hypoproteinemia on pulmonary and soft tissue edema formation. Crit Care Med 1981;9:503-508.
11. Myers GA, Conhaim RL, Rosenfeld BA, et al. Effects of pentafraction and hetastarch plasma expansion on lung and soft tissue transvascular fluid filtration. Surgery 1995;117:340-349.
12. Rackow EC, Weil MH, Macneil AR, et al. Effects of crystalloid and colloid fluids on extravascular lung water in hypoproteinemic dogs. J Appl Physiol 1987;62:2421-2425.
13. Morisaki H, Bloos F, Keys J, et al. Compared with crystalloid, colloid therapy slows progression of extrapulmonary tissue injury in septic sheep. J Appl Physiol 1994;77:1507-1518.
14. Nielsen OM, Engell HC. The importance of plasma colloid oncotic pressure for interstitial fluid volume and fluid balance after elective abdominal vascular surgery. Ann Surg 1986;203:25-29.
15. Bock JC, Barker BC, Clinton AG, et al. Post-traumatic changes in, and effect of colloid osmotic pressure on the distribution of body water. Ann Surg 1989;210:395-405.
16. Rackow EC, Falk JL, Fein IA, et al. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Crit Care Med 1983;11:839-850.
17. Marik PE, Iglesias J, Maini B. Gastric intramucosal pH changes after volume replacement with hydroxyethyl starch or crystalloid in patients undergoing elective abdominal aortic aneurysm repair. J Crit Care 1997;12:51-55.
18. Allen D Jr, Kvietys PR, Granger DN. Crystalloids versus colloids: implications in fluid therapy of dogs with intestinal obstruction. Am J Vet Res 1986;47:1751-1755.
19. Haupt MT, Rackow EC. Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin and saline solutions. Crit Care Med 1982;10:159-162.
20. Hankeln K, Radel C, Beez M, et al. Comparison of hydroxyethyl starch and lactated ringer's solution on hemodynamics and oxygen transport of critically ill patients in prospective crossover studies. Crit Care Med 1989;17:133-135.
21. Mishler JM. Synthetic plasma volume expanders: their pharmacology, safety and clinical efficacy. Clin Haematol 1984;13:75-92.
22. Traylor RJ, Pearl RG. Crystalloid versus colloid versus colloid: all colloids are not created equal. Anesth Analg 1996;83: 204-212.
23. Winslow RM. New transfusion strategies: red cell substitutes. Annu Rev Med 1999;50:337-353.
24. Treib J, Baron JF, Grauer MT, et al. An international view of hydroxyethyl starches. Intensive Care Med 1999;25:258-268.
25. Warren BB, Durieux ME. Hydroxyethyl starch: safe or not? Anesth Analg 1997;84:206-212.
26. Boldt J, Heesen M, Muller M, et al. The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients. Anesth Analg 1996;83:254-261.
27. Lazrove S, Waxman K, Shippy C, et al. Hemodynamic, blood volume, and oxygen transport responses to albumin and hydroxyethyl starch infusions in critically ill postoperative patients. Crit Care Med 1980;8:302-306.
28. Jones PA, Tomasic M, Gentry PA. Oncotic, hemodilutional, and hemostatic effects of isotonic saline and hydroxyethyl starch solutions in clinically normal ponies. Am J Vet Res 1997;58:541-548.
29. Barclay SA, Bennett D. The direct measurement of plasma colloid osmotic pressure is superior to colloid osmotic pressure derived from albumin or total protein. Intensive Care Med 1987;13:114-118.
30. Nguyen HN, Clark SL, Greenspoon J, et al. Peripartum colloid osmotic pressures: correlation with serum proteins. Obstet Gynecol 1986;68:807-810.
31. Sprung CL, Isikoff SK, Hauser M, et al. Comparison of measured and calculated colloid osmotic pressure of serum and pulmonary edema fluid in patients with pulmonary edema. Crit Care Med 1980;8:613-615.
32. Bartels C, Hadzik B, Abel M, et al. The importance of colloid osmotic pressure measurements to prevent oncotic overdosage during cardiac surgery. J Cardiovasc Surg (Torino) 1995;36:417-422.
33. Thomas LA, Brown SA. Relationship between colloid osmotic pressure and plasma protein concentration in cattle, horses, dogs and cats. Am J Vet Res 1992;53:2241-2244.
34. Brown SA, Dusza K, Boehmer J. Comparison of measured and calculated values for colloid osmotic pressure in hospitalized animals. Am J Vet Res 1994;55:910-915.
35. Lumsden JH, Rowe R, Mullen K. Hematology and biochemistry reference values for the light horse. Can J Comp Med 1980; 44:32-42.
36. Green WH. Econometric analysis. 4th ed. Upper Saddle River, NJ: Prentice Hall Inc, 2000;469.
37. Diggle PJ, Liang KY, Zeger SL. Analysis of longitudinal data. Oxford, England: Clarendon Press, 1996;117.
38. Lindsey JK. Models for repeated measurements. Oxford, England: Clarendon Press, 1997;209.
39. Stata reference manual: release 6. College Station, Tex: Stata Press, 1999;225-232, 360-369.
40. Stata Technical Bulletin. College Station, Tex: Stata Press, 1998;43:35-39.
41. Glantz SA. How to test for trends. In: Jeffers JD, Englis MR, eds. Primer of biostatistics. New York: McGraw-Hill Book Co, 1992;218-277.
42. Yacohi A, Gibson TP, McEntegart CM, et al. Pharmacokinetics of high molecular weight hydroxyethyl starch in dogs. Res Commun Chem Pathol Pharmacol 1982;36:199-204.
43. Meister D, Hermann M, Mathis GA. Kinetics of hydroxyethyl starch in horses. Schweiz Arch Tierheilkd 1992;134:329-339.
44. Moore LE, Garvey MS. The effect of hetastarch on serum colloid oncotic pressure in hypoalbuminemic dogs. J Vet Intern Med 1996;10:300-303.
45. Yacobi A, Stoll RG, Sum CY, et al. Pharmacokinetics of hydroxyethyl starch in normal subjects. J Clin Pharmacol 1982;22: 206-212.
46. Traber LD, Brazeal BA, Schmitz M, et al. Pentafraction reduces the lung lymph response after endotoxin administration in the ovine model. Cric Shock 1992;36:93-103.
47. Webb AR, Tighe D, Moss RF, et al. Advantages of a narrow-range, medium molecular weight hydroxyethyl starch for volume maintenance in a porcine model of fecal peritonitis. Crit Care Med 1991;19:409-416.
48. Conhaim RL, Watson KE, Potenza BM, et al. Pulmonary capillary sieving of hetastarch is not altered by LPS-induced sepsis. J Trauma 1999;46:800-810.
49. Collis RE, Collins PW, Gutteridge CN, et al. The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation; an in vitro study. Intensive Care Med 1994;20:37-41.